NCT01393860已完成不适用
Aliskiren Use in Diabetic Patients: Who's Using it, Why, and How is it Working ?
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Novartis
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Measure: Change in blood pressure
研究概览
简要总结
The purpose of this study is to evaluate real-world patterns of aliskiren use with a focus of change in renal function following aliskiren initiation as well as to identify "triggering events" that lead to aliskiren initiation.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 2 diabetes
- •Patients ages 18 yeras and older
- •Hypertension Diagnosis
- •Currently on at least 1 hypertensive medication
- •At least 2 lab measure before and after aliskiren initiation
排除标准
- •Inadequate chart records where microalbuminuria, serum creatinine and blood pressure data are not within 3-12 months prior to initiation of Aliskiren
- •Pregnancy
- •Development of secondary renal disease unrelated to diabetes (such as nephritis)
- •Terminal illness
- •AIDS/HIV Other protocol-defined inclusion/exclusion criteria may apply
结局指标
主要结局
Measure: Change in blood pressure
时间窗: baseline and 1 year
次要结局
- Measure: Change in urine microalbumin(baseline and 1 year)
- Measure: Change in creatinine(baseline and 1 year)
- Measure: Change in potassium levels(baseline and 1 year)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
E-health Care Process Support for Diabetes Type II PatientsDiabetes Mellitus Type II,NCT01566981University of Primorska120
尚未招募
不适用
Insulin Injection Practices in SpainDiabetesNCT06421467Fundación para la Investigación del Hospital Clínico de Valencia400
招募中
不适用
DIABASE; Diabetes Mellitus Registry in Second CareDiabetes MellitusNCT05584293Ziekenhuisgroep Twente1,500
招募中
2 期
Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney DiseaseDiabetic NephropathiesNCT05638880Mostafa Bahaa60
已完成
不适用
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)Type 1 DiabetesNCT02074384HealthPartners Institute161